English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA.

MPS-Authors
/persons/resource/persons78821

Valet,  G.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Owczarczyk, K., Passon, D., Roehrs, T., Jung, N., Taubert, D., Valet, G., et al. (2007). Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA. Zeitschrift fur Rheumatologie, 66(Suppl. Suppl. 1), 40-40.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-5F3A-0
Abstract
There is no abstract available